Cargando…

Recognition of maturity‐onset diabetes of the young in China

AIMS/INTRODUCTION: Given that mutations related to maturity‐onset diabetes of the young (MODY) are rarely found in Chinese populations, we aim to characterize the mutation spectrum of MODY pedigrees. MATERIALS AND METHODS: Maturity‐onset diabetes of the young candidate gene‐ or exome‐targeted captur...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Hua, Zhang, Yanan, Li, Maixinyue, Yan, Jinhua, Yang, Daizhi, Luo, Sihui, Zheng, Xueying, Yang, Guoqing, Li, Zhuo, Xu, Wen, Groop, Leif, Weng, Jianping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015824/
https://www.ncbi.nlm.nih.gov/pubmed/32741144
http://dx.doi.org/10.1111/jdi.13378
_version_ 1783673753447694336
author Liang, Hua
Zhang, Yanan
Li, Maixinyue
Yan, Jinhua
Yang, Daizhi
Luo, Sihui
Zheng, Xueying
Yang, Guoqing
Li, Zhuo
Xu, Wen
Groop, Leif
Weng, Jianping
author_facet Liang, Hua
Zhang, Yanan
Li, Maixinyue
Yan, Jinhua
Yang, Daizhi
Luo, Sihui
Zheng, Xueying
Yang, Guoqing
Li, Zhuo
Xu, Wen
Groop, Leif
Weng, Jianping
author_sort Liang, Hua
collection PubMed
description AIMS/INTRODUCTION: Given that mutations related to maturity‐onset diabetes of the young (MODY) are rarely found in Chinese populations, we aim to characterize the mutation spectrum of MODY pedigrees. MATERIALS AND METHODS: Maturity‐onset diabetes of the young candidate gene‐ or exome‐targeted capture sequencing was carried out in 76 probands from unrelated families fulfilling the clinical diagnostic criteria for MODY. MAF <0.01 in the GnomAD or ExAC database was used to filter significant variants. Sanger sequencing was then carried out to validate findings. Function prediction by SIFT, PolyPhen‐2 and PROVEAN or CADD was carried out in missense mutations. RESULTS: A total of 32 mutations in six genes were identified in 31 families, accounting for 40.79% of the potential MODY families. The MODY subtype detection rate was 18.42% for GCK, 15.79% for HNF1A, 2.63% for HNF4A, and 1.32% for KLF11, PAX4 and NEUROG3. Seven nonsense/frameshift mutations and four missense mutations with damaging prediction were newly identified novel mutations. The clinical features of MODY2, MODY3/1 and MODYX are similar to previous reports. Clinical phenotype of NEUROG3 p.Arg55Glufs*23 is characterized by hyperglycemia and mild intermittent abdominal pain. CONCLUSIONS: This study adds to the emerging pattern of MODY epidemiology that the proportion of MODY explained by known pathogenic genes is higher than that previously reported, and found NEUROG3 as a new causative gene for MODY.
format Online
Article
Text
id pubmed-8015824
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-80158242021-04-02 Recognition of maturity‐onset diabetes of the young in China Liang, Hua Zhang, Yanan Li, Maixinyue Yan, Jinhua Yang, Daizhi Luo, Sihui Zheng, Xueying Yang, Guoqing Li, Zhuo Xu, Wen Groop, Leif Weng, Jianping J Diabetes Investig Articles AIMS/INTRODUCTION: Given that mutations related to maturity‐onset diabetes of the young (MODY) are rarely found in Chinese populations, we aim to characterize the mutation spectrum of MODY pedigrees. MATERIALS AND METHODS: Maturity‐onset diabetes of the young candidate gene‐ or exome‐targeted capture sequencing was carried out in 76 probands from unrelated families fulfilling the clinical diagnostic criteria for MODY. MAF <0.01 in the GnomAD or ExAC database was used to filter significant variants. Sanger sequencing was then carried out to validate findings. Function prediction by SIFT, PolyPhen‐2 and PROVEAN or CADD was carried out in missense mutations. RESULTS: A total of 32 mutations in six genes were identified in 31 families, accounting for 40.79% of the potential MODY families. The MODY subtype detection rate was 18.42% for GCK, 15.79% for HNF1A, 2.63% for HNF4A, and 1.32% for KLF11, PAX4 and NEUROG3. Seven nonsense/frameshift mutations and four missense mutations with damaging prediction were newly identified novel mutations. The clinical features of MODY2, MODY3/1 and MODYX are similar to previous reports. Clinical phenotype of NEUROG3 p.Arg55Glufs*23 is characterized by hyperglycemia and mild intermittent abdominal pain. CONCLUSIONS: This study adds to the emerging pattern of MODY epidemiology that the proportion of MODY explained by known pathogenic genes is higher than that previously reported, and found NEUROG3 as a new causative gene for MODY. John Wiley and Sons Inc. 2020-09-09 2021-04 /pmc/articles/PMC8015824/ /pubmed/32741144 http://dx.doi.org/10.1111/jdi.13378 Text en © 2020 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Articles
Liang, Hua
Zhang, Yanan
Li, Maixinyue
Yan, Jinhua
Yang, Daizhi
Luo, Sihui
Zheng, Xueying
Yang, Guoqing
Li, Zhuo
Xu, Wen
Groop, Leif
Weng, Jianping
Recognition of maturity‐onset diabetes of the young in China
title Recognition of maturity‐onset diabetes of the young in China
title_full Recognition of maturity‐onset diabetes of the young in China
title_fullStr Recognition of maturity‐onset diabetes of the young in China
title_full_unstemmed Recognition of maturity‐onset diabetes of the young in China
title_short Recognition of maturity‐onset diabetes of the young in China
title_sort recognition of maturity‐onset diabetes of the young in china
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015824/
https://www.ncbi.nlm.nih.gov/pubmed/32741144
http://dx.doi.org/10.1111/jdi.13378
work_keys_str_mv AT lianghua recognitionofmaturityonsetdiabetesoftheyounginchina
AT zhangyanan recognitionofmaturityonsetdiabetesoftheyounginchina
AT limaixinyue recognitionofmaturityonsetdiabetesoftheyounginchina
AT yanjinhua recognitionofmaturityonsetdiabetesoftheyounginchina
AT yangdaizhi recognitionofmaturityonsetdiabetesoftheyounginchina
AT luosihui recognitionofmaturityonsetdiabetesoftheyounginchina
AT zhengxueying recognitionofmaturityonsetdiabetesoftheyounginchina
AT yangguoqing recognitionofmaturityonsetdiabetesoftheyounginchina
AT lizhuo recognitionofmaturityonsetdiabetesoftheyounginchina
AT xuwen recognitionofmaturityonsetdiabetesoftheyounginchina
AT groopleif recognitionofmaturityonsetdiabetesoftheyounginchina
AT wengjianping recognitionofmaturityonsetdiabetesoftheyounginchina